1. Home
  2. IXHL vs PYN Comparison

IXHL vs PYN Comparison

Compare IXHL & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IXHL
  • PYN
  • Stock Information
  • Founded
  • IXHL 2001
  • PYN 2002
  • Country
  • IXHL Australia
  • PYN United States
  • Employees
  • IXHL N/A
  • PYN N/A
  • Industry
  • IXHL
  • PYN Investment Managers
  • Sector
  • IXHL
  • PYN Finance
  • Exchange
  • IXHL Nasdaq
  • PYN Nasdaq
  • Market Cap
  • IXHL 39.2M
  • PYN 34.5M
  • IPO Year
  • IXHL N/A
  • PYN N/A
  • Fundamental
  • Price
  • IXHL $1.93
  • PYN $5.74
  • Analyst Decision
  • IXHL
  • PYN
  • Analyst Count
  • IXHL 0
  • PYN 0
  • Target Price
  • IXHL N/A
  • PYN N/A
  • AVG Volume (30 Days)
  • IXHL 24.2K
  • PYN 19.9K
  • Earning Date
  • IXHL 11-14-2024
  • PYN 01-01-0001
  • Dividend Yield
  • IXHL N/A
  • PYN 5.07%
  • EPS Growth
  • IXHL N/A
  • PYN N/A
  • EPS
  • IXHL N/A
  • PYN N/A
  • Revenue
  • IXHL $86,000.00
  • PYN N/A
  • Revenue This Year
  • IXHL $3,817.06
  • PYN N/A
  • Revenue Next Year
  • IXHL $66.67
  • PYN N/A
  • P/E Ratio
  • IXHL N/A
  • PYN N/A
  • Revenue Growth
  • IXHL N/A
  • PYN N/A
  • 52 Week Low
  • IXHL $1.50
  • PYN $4.84
  • 52 Week High
  • IXHL $8.47
  • PYN $6.60
  • Technical
  • Relative Strength Index (RSI)
  • IXHL 52.16
  • PYN 46.37
  • Support Level
  • IXHL $1.71
  • PYN $5.54
  • Resistance Level
  • IXHL $2.19
  • PYN $5.79
  • Average True Range (ATR)
  • IXHL 0.16
  • PYN 0.05
  • MACD
  • IXHL -0.00
  • PYN 0.01
  • Stochastic Oscillator
  • IXHL 41.12
  • PYN 80.00

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

Share on Social Networks: